Program overview
Context
Indication: Prostate Cancer Castration-resistant Prostate Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: MBrace Therapeutics
ADC is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Prostate Cancer Castration-resistant Prostate Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: MBrace Therapeutics
Registry: 0/5
Timeline: 0/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 0/5
https://clinicaltrials.gov/study/NCT07145255 | https://clinicaltrials.gov/study/NCT07394218
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT07145255 | Low Signal (RECRUITING) | None | Low Signal | strict_eligibility_signal |
| NCT07394218 | Low Signal (RECRUITING) | None | Low Signal | few_sites_large_trial_signal |